Sale!

PRRT2 Gene DYT10 Genetic Test

4,400 د.إ

-21%

The PRRT2 Gene DYT10 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PRRT2 gene, which are linked to DYT10 (also known as Paroxysmal Kinesigenic Dyskinesia or PKD). This condition is characterized by sudden, brief, involuntary movements or spasms triggered by sudden movements. The test is particularly important for individuals showing symptoms of PKD or those with a family history of the condition, as it can provide a definitive diagnosis and guide treatment and management strategies.

Performed at DNA Labs UAE, a leading facility in genetic testing, the PRRT2 Gene DYT10 Genetic Test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing techniques to detect any mutations in the PRRT2 gene that are indicative of DYT10.

The cost of the test is 4400 AED, which reflects the comprehensive nature of the genetic analysis and the expertise required to interpret the results. While the price may seem high, the value of a precise diagnosis cannot be understated, as it opens the door to targeted treatments and interventions that can significantly improve the quality of life for individuals affected by this condition.

Overall, the PRRT2 Gene DYT10 Genetic Test is a crucial tool in the diagnosis and management of Paroxysmal Kinesigenic Dyskinesia, providing patients and their families with the answers they need to navigate this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PRRT2 Gene DYT10 Genetic Test

Components: PRRT2 Gene DYT10 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PRRT2 Gene DYT10 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRRT2 Gene DYT10.

Test Details: The PRRT2 gene is associated with a rare genetic movement disorder called paroxysmal dyskinesia. The disorder is characterized by sudden, involuntary movements or spasms that can affect the arms, legs, face, or trunk. The movements can be triggered by stress, fatigue, or certain medications. The PRRT2 gene is also known as DYT10, and mutations in this gene have been linked to other movement disorders, such as benign familial infantile seizures and episodic ataxia. NGS genetic testing for the PRRT2 gene can help diagnose paroxysmal dyskinesia and other related movement disorders. The test involves sequencing the DNA of the patient to identify any mutations or variations in the PRRT2 gene. Early diagnosis and treatment of paroxysmal dyskinesia can help manage symptoms and improve quality of life for patients. Genetic testing can also help identify carriers of the PRRT2 gene mutation, which can be important for family planning and genetic counseling.

Test Name PRRT2 Gene DYT10 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PRRT2 Gene DYT10 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PRRT2 Gene DYT10
Test Details

The PRRT2 gene is associated with a rare genetic movement disorder called paroxysmal dyskinesia. The disorder is characterized by sudden, involuntary movements or spasms that can affect the arms, legs, face, or trunk. The movements can be triggered by stress, fatigue, or certain medications.

The PRRT2 gene is also known as DYT10, and mutations in this gene have been linked to other movement disorders, such as benign familial infantile seizures and episodic ataxia.

NGS genetic testing for the PRRT2 gene can help diagnose paroxysmal dyskinesia and other related movement disorders. The test involves sequencing the DNA of the patient to identify any mutations or variations in the PRRT2 gene.

Early diagnosis and treatment of paroxysmal dyskinesia can help manage symptoms and improve quality of life for patients. Genetic testing can also help identify carriers of the PRRT2 gene mutation, which can be important for family planning and genetic counseling.